You are here: Home » References

References

Papers Published Citing Chris Chiodo, ASI Instruments:

S.T Fricke, R Vink, C Chiodo, I Cernak, L Ileva, A.I Faden, Consistent and reproducible slice selection in rodent brain using a novel stereotaxic device for MRI, Journal of Neuroscience Methods, Volume 136, Issue 1, 15 June 2004, Pages 99-102, ISSN 0165-0270, 10.1016/j.jneumeth.2004.01.003.  Keywords: Stereotaxic; Rat; Mouse; Magnetic resonance spectroscopy; CT; Neurotrauma; Stroke; PET

http://www.sciencedirect.com/science/article/pii/S0165027004000214

David W. Holdsworth, Sarah A. Detombe, Chris Chiodo, Stanley T. Fricke and Maria Drangova, “Implementation and assessment of an animal management system for small-animal micro-CT / micro-SPECT imaging”, Proc. SPIE 7965, 79650N (2011); doi:10.1117/12.878855

http://dx.doi.org/10.1117/12.878855

Emmanuel Wilson, Chris Chiodo, Kenneth H. Wong, Stanley Fricke, Mira Jung and Kevin Cleary, “Robotically assisted small animal MRI-guided mouse biopsy”, Proc. SPIE 7625, 762520 (2010);

Journal Articles Published Citing ASI Instruments:
(100 out of 100 citings displayed below )

  1. Immunohistochemical and neurochemical correlates of learning deficits in aged rats J. Stemmelin, C. Lazarus, S. Cassel, C. Kelche & J.-C. Cassel Neuroscience, 2000, 96:2:275-289
  2. The effectiveness of two intensities of psychosocial treatment for cocaine dependence Donna M. Coviello, Arthur I. Alterman, Megan J. Rutherford, John S. Cacciola, James R. McKay & Dave A. Zanis Drug and Alcohol Dependence, 2001, 61:2:145 – 154
  3. The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients John S. Cacciola, Arthur I. Alterman, Megan J. Rutherford, James R. McKay & Frank D. Mulvaney Drug and Alcohol Dependence, 2001, 61:3:271 – 280
  4. Polarized Dendritic Transport and the AP-1 µ1 Clathrin Adaptor UNC-101 Localize Odorant Receptors to Olfactory Cilia Noelle D. Dwyer, Carolyn E. Adler, Justin Gage Crump, Noelle D. L’Etoile & Cornelia I. Bargmann Neuron, 2001, 31:2:277-287
  5. Continuous, categorical, and time to event cocaine use outcome variables: degree of intercorrelation and sensitivity to treatment group differences James R. McKay, Arthur I. Alterman, Janelle M. Koppenhaver, Frank D. Mulvaney, Gregory B. Bovasso & Kathleen Ward Drug and Alcohol Dependence, 2001, 62:1:19 – 30
  6. Panic-agoraphobic spectrum: reliability and validity of assessment instruments [EP_effect_tig_render::dump] Unknown Tag M.K.M. KatherineShearaCorresponding author. Tel.: +1-412-624-1340; fax: +1-412-624-6644, shearmk@msx.upmc.edu Serotonin transporter polymorphisms and measures of impulsivity, aggression, and sensation seeking among African-American cocaine-dependent individuals Ashwin A. Patkar, Wade H. Berrettini, Margret Hoehe, Charles C. Thornton, Edward Gottheil, Kevin Hill & Stephen P. Weinstein Psychiatry Research, 2002, 110:2:103-115
  7. Family history influence on drug abuse severity and treatment outcome Roy W. Pickens, Kenzie L. Preston, Donna R. Miles, Anne E. Gupman, Eric O. Johnson, David B. Newlin, Jim Soriano, Marianne B.M. van den Bree & Annie Umbricht Drug and Alcohol Dependence, 2001, 61:3:261 – 270
  8. Early drop-outs, late drop-outs and completers: Differences in the continuation phase of a clinical trial Shamsah B. Sonawalla, Amy H. Farabaugh, Vinita M. Leslie, Joel A. Pava, John D. Matthews & Maurizio Fava Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2002, 26:3:415-419
  9. Suggested specifications for a standardized Addiction Severity Index database. Carise D, McLellan AT, Cacciola J, Love M, Cook T, Bovasso G, Lam V J Subst Abuse Treat 2001 Apr 20:3 239-44
  10. Assessing the needs of substance abusing women. Psychometric data on the psychosocial history. Comfort M, Zanis DA, Whiteley MJ, Kelly_Tyler A, Kaltenbach KA J Subst Abuse Treat 1999 Jul-Sep 17:1-2 79-83
  11. Reproducible and efficient murine CNS gene delivery using a microprocessor-controlled injector Andrew I. Brooks, Marc W. Halterman, Christopher A. Chadwick, Beverly L. Davidson, Mary Haak-Frendscho, Clyde Radel, Chris Porter & Howard J. Federoff Journal of Neuroscience Methods, 1998, 80:2:137 – 147
  12. Recombinant GABAB receptors formed from GABAB1 and GABAB2 subunits selectively inhibit N-type Ca2+ channels in NG108-15 cells Alison Easter & Austen E. Spruce European Journal of Pharmacology, 2002, 440:1:17-25
  13. Validation of the Addiction Severity Index in French-speaking alcoholic patients. Daeppen JB, Burnand B, Schnyder C, Bonjour M, Pecoud A, Yersin B J Stud Alcohol 1996 Nov 57:6 585-90
  14. Addiction Severity Index: experience in the field. Grissom GR, Bragg A Int J Addict 1991 Jan 26:1 55-64
  15. Nitrergic stimulation of the locus coeruleus modulates blood pressure and heart rate in the anaesthetized rat S.T. Yao, D.I. Finkelstein & A.J. Lawrence Neuroscience, 1999, 91:2:621-629
  16. Opposite effects of GABAA and GABAC receptor antagonists on the b-wave of ERG recorded from the isolated rat retina Natalia V. Kapousta-Bruneau Vision Research, 2000, 40:13:1653 – 1665
  17. L-type calcium channels modulate glutamate-driven bursting activity in the nucleus accumbens in vivo Donald C. Cooper & Francis J. White Brain Research, 2000, 880:1-2:212-218
  18. Rural and urban differences in patients with a dual diagnosis Kim T. Mueser, Susan M. Essock, Robert E. Drake, Rosemarie S. Wolfe & Linda Frisman Schizophrenia Research, 2001, 48:1:93-107
  19. Substance P release in the feline nucleus tractus solitarius during ergoreceptor but not baroreceptor afferent signaling Carole A. Williams, Angela Reifsteck, Toby A. Hampton & Bonnie Fry Brain Research, 2002, 944:1-2:19-31
  20. Assessing substance use in multiproblem patients: reliability and validity of the Addiction Severity Index in a mental hospital population. Appleby L, Dyson V, Altman E, Luchins DJ J Nerv Ment Dis 1997 Mar 185:3 159-65
  21. Substance abuse, pathological gambling, and impulsiveness Nancy M. Petry Drug and Alcohol Dependence, 2001, 63:1:29 – 38
  22. Decrease of vigilance assessed by EEG-mapping in Type I diabetic patients with history of recurrent severe hypoglycaemia Kinga Howorka, J. Pumprla, B. Saletu, P. Anderer, Martina Krieger & A. Schabmann Psychoneuroendocrinology, 2000, 25:1:85-105
  23. Benefit-cost analysis of addiction treatment: methodological guidelines and empirical application using the DATCAP and ASI. French MT, Salome HJ, Sindelar JL, McLellan AT Health Serv Res 2002 Apr 37:2 433-55
  24. Screening for psychopathology in the clinical practice. Eland_Goossensen A, van de Goor I, Garretsen H, Schudel J J Subst Abuse Treat 1997 Nov-Dec 14:6 585-91
  25. Is the Addiction Severity Index a reliable and valid assessment instrument among clients with severe and persistent mental illness and substance abuse disorders? Zanis DA, McLellan AT, Corse S Community Ment Health J 1997 Jun 33:3 213-27
  26. Validation of the Christo Inventory for Substance-misuse Services (CISS): a simple outcome evaluation tool George Christo, Sally Spurrell & Ron Alcorn Drug and Alcohol Dependence, 2000, 59:2:189 – 197
  27. Early-onset of illicit substance use is associated with greater axis-II comorbidity, not with axis-I comorbidity Ingmar H.A. Franken & Vincent M. Hendriks Drug and Alcohol Dependence, 2000, 59:3:305 – 308
  28. Ultrasonic vocalisation emitted by infant rodents: a tool for assessment of neurobehavioural development Igor Branchi, Daniela Santucci & Enrico Alleva Behavioural Brain Research, 2001, 125:1-2:49 – 56
  29. Reliability and validity of the Panic Disorder Severity Scale: replication and extension [EP_effect_tig_render::dump] Unknown Tag M.K.M. KatherineShear**Corresponding author. Tel.: +1-412-624-1340; fax: +1-412-624-6644, shearmk@msx.upmc.eduP.PaolaRucciJ.JennaWilliamsE.EllenFrankV.VictoriaGrochocinskiJ.JoniVander BiltP.PatriciaHouckT.TraceyWangDepartment of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh, 3811 O’Hara Street, Pittsburgh, PA 15213, USAReliability and validity of the Panic Disorder Severity Scale: replication and extensionJournal of Psychiatric Research355200109293-29620010615> Reliability and validity of the German version of the European Addiction Severity Index (EuropASI). Scheurich A, Muller MJ, Wetzel H, Anghelescu I, Klawe C, Ruppe A, Lorch B, Himmerich H, Heidenreich M, Schmid G, Hautzinger M, Szegedi A J Stud Alcohol 2000 Nov 61:6 916-9
  30. Effect of hypergravity on the mouse basal expression of NGF and BDNF in the retina, visual cortex and geniculate nucleus: correlative aspects with NPY immunoreactivity L. Aloe, M. Fiore, D. Santucci, T. Amendola, A. Antonelli, N. Francia, G. Corazzi & E. Alleva Neuroscience Letters, 2001, 302:1:29-32
  31. Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss A.I. Brooks, C.A. Chadwick, H.A. Gelbard, D.A. Cory-Slechta & H.J. Federoff Brain Research, 1999, 823:1-2:1-10
  32. Hostility is associated with a heightened prolactin response to meta-chlorophenylpiperazine in abstinent cocaine addicts Leonard Handelsman, Rene S. Kahn, Christopher Sturiano, Paul J. Rinaldi, Steven Gabriel, James P. Schmeidler, David P. Bernstein, Larry Siever & Thomas B. Cooper Psychiatry Research, 1998, 80:1:1-12
  33. Voucher-based reinforcement of opiate abstinence during methadone detoxification Elias Robles, Maxine L. Stitzer, Eric C. Strain, George E. Bigelow & Kenneth Silverman Drug and Alcohol Dependence, 2002, 65:2:179 – 189
  34. Screening and diagnosis of anxiety and mood disorders in substance abuse patients. Franken IH, Hendriks VM Am J Addict 2001 Winter 10:1 30-9
  35. The effect of spinal instrumentation on lumbar intradiscal pressure. Abe E, Nickel T, Buttermann GR, Lewis JL, Transfeldt EE Tohoku J Exp Med 1999 Mar 187:3 237-47
  36. Effect of the reversible monoamine oxidase-A inhibitor befloxatone on the rat 5-hydroxytryptamine neurotransmission Nasser Haddjeri, Claude De Montigny, Olivier Curet & Pierre Blier European Journal of Pharmacology, 1998, 343:2-3:179-192
  37. Normal and drug-induced locomotor behavior in aging: comparison to evoked DA release and tissue content in Fischer 344 rats Meleik A. Hebert & Greg A. Gerhardt Brain Research, 1998, 797:1:42-54
  38. Involvement of Opioid µ1-Receptors in Opioid-Induced Acceleration of Striatal and Limbic Dopaminergic Transmission T. P. Piepponen, A. Honkanen, T. Kivastik, A. Zharkovsky, A. Turtia, J. A. V. Mikkola & L. Ahtee Pharmacology Biochemistry & Behavior, 1999, 63:2:245-252
  39. Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia Kazushi Takahashi, Andrew A. Pieper, Sidney E. Croul, Jie Zhang, Solomon H. Snyder & Joel H. Greenberg Brain Research, 1999, 829:1-2:46-54
  40. Initiating abstinence in cocaine abusing dually diagnosed homeless persons Jesse B. Milby, Joseph E. Schumacher, Cecelia McNamara, Dennis Wallace, Stuart Usdan, Troy McGill & Max Michael Drug and Alcohol Dependence, 2000, 60:1:55 – 67
  41. Functional reconstitution of a heteromeric cyclic nucleotide-gated channel of Caenorhabditis elegans in cultured cells Hidetoshi Komatsu, Young-Ho Jin, Noelle L’Etoile, Ikue Mori, Cornelia I. Bargmann, Norio Akaike & Yasumi Ohshima Brain Research, 1999, 821:1:160-168
  42. Three-vessel occlusion using a micro-clip for the proximal left middle cerebral artery produces a reliable neocortical infarct in rats Hiroji Yanamoto, Izumi Nagata, Nobuo Hashimoto & Haruhiko Kikuchi Brain Research Protocols, 1998, 3:2:209-220
  43. Anxiolytic effects of the neuroactive steroid pregnanolone (3-OH-5-pregnan-20-one) after microinjection in the dorsal hippocampus and lateral septum Daniel Bitran, Matthew Dugan, Phyllis Renda, Rebecca Ellis & Melissa Foley Brain Research, 1999, 850:1-2:217-224
  44. Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpression David M. Donovan, Lucinda L. Miner, Michael P. Perry, Randal S. Revay, Lawrence G. Sharpe, Serge Przedborski, Vladimir Kostic, Rex M. Philpot, Cheryl L. Kirstein, Richard B. Rothman, Charles W. Schindler & George R. Uhl Molecular Brain Research, 1999, 73:1-2:37-49
  45. A cocaine analog, 2-propanoyl-3-(4-tolyl)-tropane (PTT), reduces tyrosine hydroxylase in the mesolimbic dopamine pathway Willard M. Freeman, George J. Yohrling IV, James B. Daunais, Lynda Gioia, Stephanie L. Hart, Linda J. Porrino, Huw M.L. Davies & Kent E. Vrana Drug and Alcohol Dependence, 2000, 61:1:15 – 21
  46. Effect of sustained administration of the 5-HT1A receptor agonist flesinoxan on rat 5-HT neurotransmission Nasser Haddjeri, Catherine Ortemann, Claude de Montigny & Pierre Blier European Neuropsychopharmacology, 1999, 9:5:427-440
  47. Comparison of the Proopiomelanocortin and Proenkephalin Opioid Peptide Systems in Brain Regions of the Alcohol-Preferring C57BL/6 and Alcohol-Avoiding DBA/2 Mice Neil T. Jamensky & Christina Gianoulakis Alcohol, 1999, 18:2-3:177-187
  48. Effect of Ergotamine on Serotonin-Mediated Responses in the Rodent and Human Brain Nasser Haddjeri, Bernard Seletti, François Gilbert, Claude de Montigny & Pierre Blier Neuropsychopharmacology, 1998, 19:5:365-380
  49. MRI of the Hippocampus in Alzheimer’s Disease: Sensitivity, Specificity, and Analysis of the Incorrectly Classified Subjects M. P. Laakso, H. Soininen, K. Partanen, M. Lehtovirta, M. Hallikainen, T. Hänninen, E.-L. Helkala, P. Vainio & P. J. Riekkinen Sr Neurobiology of Aging, 1998, 19:1:23-31
  50. Volumes of the Entorhinal and Perirhinal Cortices in Alzheimer’s Disease K. Juottonen, M. P. Laakso, R. Insausti, M. Lehtovirta, A. Pitkänen, K. Partanen & H. Soininen Neurobiology of Aging, 1998, 19:1:15-22
  51. Phosphorylation of Tau, A-Formation, and Apoptosis After In Vivo Inhibition of PP-1 and PP-2A T. Arendt, M. Holzer, R. Fruth, M. K. Brückner & U. Gärtner Neurobiology of Aging, 1998, 19:1:3-13
  52. Nicotinic 7 receptors protect against glutamate neurotoxicity and neuronal ischemic damage S. Shimohama, D.L. Greenwald, D.H. Shafron, A. Akaika, T. Maeda, S. Kaneko, J. Kimura, C.E. Simpkins, A.L. Day & E.M. Meyer Brain Research, 1998, 779:1-2:359-363
  53. Mechanism underlying potentiation by progesterone of the kainate-induced current in cultured neurons Fong-Sen Wu, Hui-Min Yu & Jing-Jane Tsai Brain Research, 1998, 779:1-2:354-358
  54. Altered [Ca2+] homeostasis in PC12 cells after nerve growth factor deprivation Gwenda Dispersyn, Rony Nuydens, Mirjam de Jong, Marcel Borgers & Hugo Geerts Brain Research, 1998, 779:1-2:350-353
  55. Attenuation of motor nerve terminal repetitive discharge by the 21-aminosteroid tirilazad: evidence of a neural calcium antagonist action Edward D. Hall & Patricia A. Yonkers Brain Research, 1998, 779:1-2:346-349
  56. Dendro-dendritic connections between motoneurons in the rat spinal cord: an electron microscopic investigation J.J.L. van der Want, A. Gramsbergen, J. IJkema-Paassen, H. de Weerd & R.S.B. Liem Brain Research, 1998, 779:1-2:342-345
  57. The aged suprachiasmatic nucleus is phase-shifted by cAMP in vitro Norman F. Ruby, Dale M. Edgar, H. Craig Heller & Joseph D. Miller Brain Research, 1998, 779:1-2:338-341
  58. Effects of toluene on tonic firing and membrane properties of rat medial vestibular nucleus neurones in vitro Anna K. Magnusson, M. Roslan Sulaiman, Mayank B. Dutia & Richard Tham Brain Research, 1998, 779:1-2:334-337
  59. Depolarization triggers intracellular magnesium surge in cultured dorsal root ganglion neurons H. Kato, H. Gotoh, M. Kajikawa & K. Suto Brain Research, 1998, 779:1-2:329-333
  60. Regional differences in hippocampal excitability manifested by paired-pulse stimulation of genetically epileptic El mice Y. Fueta, H. Kawano, T. Ono, T. Mita, K. Fukata & K. Ohno Brain Research, 1998, 779:1-2:324-328
  61. Effect of pentylenetetrazol treatment on cholecystokinin mRNA and peptide levels in rat hippocampus and cortex Katsumichi Takeda, Kousuke Nakata, Shinji Takahashi, Toshiyuki Chikuma & Takeshi Kato Brain Research, 1998, 779:1-2:320-323
  62. In vivo long-term potentiation in the insular cortex: NMDA receptor dependence Martha L. Escobar, Vincent Chao & Federico Bermúdez-Rattoni Brain Research, 1998, 779:1-2:314-319
  63. M100907, a highly selective 5-HT2A receptor antagonist and a potential atypical antipsychotic drug, facilitates induction of long-term potentiation in area CA1 of the rat hippocampal slice Rex Y. Wang & Viktor L. Arvanov Brain Research, 1998, 779:1-2:309-313
  64. Biophysical properties of descending brain neurons in larval lamprey David T. Rouse, Xiao Quan & Andrew D. McClellan Brain Research, 1998, 779:1-2:301-308
  65. Mild hypothermia reduces the rate of metabolism of arachidonic acid following postischemic reperfusion Masaru Kubota, Makoto Nakane, Koji Narita, Tadayoshi Nakagomi, Akira Tamura, Harumi Hisaki, Hiroyuki Shimasaki & Nobuo Ueta Brain Research, 1998, 779:1-2:297-300
  66. Resistance to anoxic injury in the dorsal columns of adult rat spinal cord following demyelination Toshio Imaizumi, Jeffery D. Kocsis & Stephen G. Waxman Brain Research, 1998, 779:1-2:292-296
  67. Phenylethanolamine N-methyltransferase mRNA in rat hypothalamus and cerebellum John L. Andreassi II, William B. Eggleston, Guillian Fu & Jennifer K. Stewart Brain Research, 1998, 779:1-2:289-291
  68. Reversal of ischemic-induced chronic memory dysfunction in aging rats with a free radical scavenger–glycolytic intermediate combination J.C. de la Torre, N. Nelson, R.J. Sutherland & B.A. Pappas Brain Research, 1998, 779:1-2:285-288
  69. Crossed inhibition of the soleus H reflex during passive pedalling movement Jianguo Cheng, John D. Brooke, John E. Misiaszek & William R. Staines Brain Research, 1998, 779:1-2:280-284
  70. Carbonic anhydrase isozyme II immunoreactivity in the mechanoreceptive Ruffini endings of the periodontal ligament in rat incisor Kanako Ochi, Satoshi Wakisaka, Suk Hyun Youn, Kooji Hanada & Takeyasu Maeda Brain Research, 1998, 779:1-2:276-279
  71. The pH buffering capacity of hippocampal slices from young adult and aged rats Eugene L. Roberts Jr. & Ching-Ping Chih Brain Research, 1998, 779:1-2:271-275
  72. Hepatocyte growth factor (HGF/SF) in Alzheimer’s disease H. Fenton, P.W. Finch, J.S. Rubin, J.M. Rosenberg, W.G. Taylor, V. Kuo-Leblanc, M. Rodriguez-Wolf, A. Baird, H.M. Schipper & E.G. Stopa Brain Research, 1998, 779:1-2:262-270
  73. Interaction of angiotensin II and adenosine receptors in pentylenetetrazol-induced kindling in mice Vasil P. Georgiev & Jane D. Tchekalarova Brain Research, 1998, 779:1-2:259-261
  74. Expression of Ca2+-dependent (classical) PKC mRNA isoforms after transient cerebral ischemia in gerbil hippocampus Barbara Zabocka, Katarzyna Maternicka, Teresa Zalewska & Krystyna Domaska-Janik Brain Research, 1998, 779:1-2:254-258
  75. Distinct mechanisms for expression of Fos-like immunoreactivity and synaptic potentiation in telencephalic hyperstriatum of the quail chick Shin Yanagihara, Tohru Yagi & Toshiya Matsushima Brain Research, 1998, 779:1-2:240-253
  76. Death of transcallosal neurons after close axotomy Paul S. Fishman & Deborah A. Parks Brain Research, 1998, 779:1-2:231-239
  77. The effects of L-deprenyl treatment, alone and combined with GM1 ganglioside, on striatal dopamine content and substantia nigra pars compacta neurons David S. Rothblat & J.S. Schneider Brain Research, 1998, 779:1-2:226-230
  78. Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome Bengt E. Hildebrand, George G. Nomikos, Peter Hertel, Björn Schilström & Torgny H. Svensson Brain Research, 1998, 779:1-2:214-225
  79. The role of afferents to the ventral tegmental area in the handling stress-induced increase in the release of dopamine in the medial prefrontal cortex: a dual-probe microdialysis study in the rat brain Paolo Enrico, Marjan Bouma, Jan B. de Vries & Ben H.C. Westerink Brain Research, 1998, 779:1-2:205-213
  80. Metabolic inhibition potentiates AMPA-induced Ca2+ fluxes and neurotoxicity in rat cerebellar granule cells Gvido Cebers, Aleta Cebere & Sture Liljequist Brain Research, 1998, 779:1-2:194-204
  81. Decline of circadian photosensitivity associated with retinal degeneration in CBA/J-rd/rd mice Takashi Yoshimura & Shizufumi Ebihara Brain Research, 1998, 779:1-2:188-193
  82. Differential effects of interleukin (IL)-1, IL-2 and IL-6 on responding for rewarding lateral hypothalamic stimulation Hymie Anisman, L. Kokkinidis, Thomas Borowski & Z. Merali Brain Research, 1998, 779:1-2:177-187
  83. Effects of NMDA receptor glycine recognition site antagonism on cerebral metabolic rate for glucose and cerebral blood flow in the conscious rat Yuji Morimoto, Bo Wu, Robert D. Bart, Yoshiko Morimoto, Robert D. Pearlstein & David S. Warner Brain Research, 1998, 779:1-2:170-176
  84. Opioid supraspinal analgesic synergy between the amygdala and periaqueductal gray in rats Zoran W. Pavlovic & Richard J. Bodnar Brain Research, 1998, 779:1-2:158-169
  85. Long-term kindling and interictal emotionality in rats: effect of stimulation site Lisa E. Kalynchuk, John P.J. Pinel & Dallas Treit Brain Research, 1998, 779:1-2:149-157
  86. Rapid shifts in receptive fields of cells in trigeminal subnucleus interpolaris following infraorbital nerve transection in adult rats Bradley G. Klein, Carl F. White & Jeanette R. Duffin Brain Research, 1998, 779:1-2:136-148
  87. Recovery of rat skeletal muscles after partial denervation is enhanced by treatment with nifedipine C.M. White & G. Vrbová Brain Research, 1998, 779:1-2:125-135
  88. Castration reduces olfactory bulb norepinephrine transporter function as indicated by responses to noradrenergic uptake blockers Yili Shang & Dean E. Dluzen Brain Research, 1998, 779:1-2:119-124
  89. Antinociception following opioid stimulation of the basolateral amygdala is expressed through the periaqueductal gray and rostral ventromedial medulla Fred J. Helmstetter, Sheralee A. Tershner, Laura H. Poore & Patrick S.F. Bellgowan Brain Research, 1998, 779:1-2:104-118
  90. Organization of choline acetyltransferase-containing structures in the cranial nerve motor nuclei and spinal cord of the monkey Tomoyuki Ichikawa & Toshio Shimizu Brain Research, 1998, 779:1-2:96-103
  91. Facilitation of female rat lordosis behavior by hypothalamic infusion of 5-HT2A/2C receptor agonists A. Wolf, M. Caldarola-Pastuszka & L. Uphouse Brain Research, 1998, 779:1-2:84-95
  92. Intraventricular GLP-1 reduces short- but not long-term food intake or body weight in lean and obese rats Jamie C.K. Donahey, Gertjan van Dijk, Stephen C. Woods & Randy J. Seeley Brain Research, 1998, 779:1-2:75-83
  93. D3 dopamine receptor mRNA is widely expressed in the human brain Michio Suzuki, Yasmin L. Hurd, Pierre Sokoloff, Jean-Charles Schwartz & Göran Sedvall Brain Research, 1998, 779:1-2:58-74
  94. Effect of superior cervical ganglionectomy on catecholamine concentration in rat cochlea Pablo Gil-Loyzaga, M. Angeles Vicente-Torres, Agustín Arce, Daniel P. Cardinali & Ana Esquifino Brain Research, 1998, 779:1-2:53-57
  95. The effect of morphine on responses of mediodorsal thalamic nuclei and nucleus submedius neurons to colorectal distension in the rat Shou-wei Yang, Kenneth A. Follett, John G. Piper & Timothy J. Ness Brain Research, 1998, 779:1-2:41-52
  96. Muscimol increases acetylcholine release by directly stimulating adult striatal cholinergic interneurons Ivan S. Login, Shanthi N. Pal, Donna T. Adams & Paul E. Gold Brain Research, 1998, 779:1-2:33-40
  97. Neuroanatomical patterns of Fos-like immunoreactivity induced by naltrexone in food-restricted and ad libitum fed rats Kenneth D. Carr, Tina H. Park, Yi Zhang & Eric A. Stone Brain Research, 1998, 779:1-2:26-32
  98. 2,5-Anhydro-D-mannitol induces Fos-like immunoreactivity in hindbrain and forebrain: relationship to eating behavior Charles C. Horn & Mark I. Friedman Brain Research, 1998, 779:1-2:17-25

Journal Articles Published Citing Our Rodent Brain Matrix: ( 100 out of 839 citings displayed below )

  1. Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins T. Herdegen & J.D. Leah Brain Research Reviews, 1998, 28:3:370-490
  2. Glutamate uptake Niels C. Danbolt Progress in Neurobiology, 2001, 65:1:1 – 105
  3. Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease M.G. Murer, Q. Yan & R. Raisman-Vozari Progress in Neurobiology, 2001, 63:1:71-124
  4. Pharmacology and behavioral pharmacology of the mesocortical dopamine system T.M. Tzschentke Progress in Neurobiology, 2001, 63:3:241 – 320
  5. Catecholamine systems in the brain of vertebrates: new perspectives through a comparative approach Wilhelmus J.A.J. Smeets & Agustin González Brain Research Reviews, 2000, 33:2-3:308-379
  6. The induction of pain: an integrative review Mark J. Millan Progress in Neurobiology, 1999, 57:1:1-164
  7. Alzheimer’s disease as a disorder of mechanisms underlying structural brain self-organization T. Arendt Neuroscience, 2001, 102:4:723-765
  8. A review of central 5-HT receptors and their function Nicholas M. Barnes & Trevor Sharp Neuropharmacology, 1999, 38:8:1083 – 1152
  9. Chronic ethanol consumption:from neuroadaptation to neurodegeneration Fabio Fadda & Zvani L. Rossetti Progress in Neurobiology, 1998, 56:4:385-431
  10. Anticancer drug resistance in primary human brain tumors Markus Bredel Brain Research Reviews, 2001, 35:2:161-204
  11. Inflammation and Alzheimer’s disease Haruhiko Akiyama, Steven Barger, Scott Barnum, Bonnie Bradt, Joachim Bauer, Greg M. Cole, Neil R. Cooper, Piet Eikelenboom, Mark Emmerling, Berndt L. Fiebich, Caleb E. Finch, Sally Frautschy, W.S.T. Griffin, Harald Hampel, Michael Hull, Gary Landreth, Lih–Fen Lue, Robert Mrak, Ian R. Mackenzie, Patrick L. McGeer, M. Kerry O’Banion, Joel Pachter, Guilio Pasinetti, Carlos Plata–Salaman, Joseph Rogers, Russell Rydel, Yong Shen, Wolfgang Streit, Ronald Strohmeyer, Ikuo Tooyoma, Freek L. Van Muiswinkel, Robert Veerhuis, Douglas Walker, Scott Webster, Beatrice Wegrzyniak, Gary Wenk & Tony Wyss–Coray Neurobiology of Aging, 2000, 21:3:383-421
  12. Neuroprotective strategies for basal ganglia degeneration: Parkinson’s and Huntington’s diseases Tajrena Alexi, Cesario V. Borlongan, Richard L.M. Faull, Chris E. Williams, Ross G. Clark, Peter D. Gluckman & Paul E. Hughes Progress in Neurobiology, 2000, 60:5:409-470
  13. Neuronal–glial interactions and behaviour P.R. Laming, H. Kimelberg, S. Robinson, A. Salm, N. Hawrylak, C. Müller, B. Roots & K. Ng Neuroscience and Biobehavioral Reviews, 2000, 24:3:295-340
  14. Drug interactions at GABAA receptors Esa R. Korpi, Gerhard Gründer & Hartmut Lüddens Progress in Neurobiology, 2002, 67:2:113-159
  15. Substantia innominata: a notion which impedes clinical–anatomical correlations in neuropsychiatric disorders L. Heimer, R. E. Harlan, G. F. Alheid, M. M. Garcia & J. de Olmos Neuroscience, 1997, 76:4:957-1006
  16. Arginine metabolism and the synthesis of nitric oxide in the nervous system Heinrich Wiesinger Progress in Neurobiology, 2001, 64:4:365 – 391
  17. Drug delivery to damaged brain Eng H. Lo, Aneesh B. Singhal, Vladimir P. Torchilin & N. Joan Abbott Brain Research Reviews, 2001, 38:1-2:140-148
  18. The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum D. Joel & I. Weiner Neuroscience, 2000, 96:3:451-474
  19. Distribution, biochemistry and function of striatal adenosine A2A receptors Per Svenningsson, Catherine Le Moine, Gilberto Fisone & Bertil B. Fredholm Progress in Neurobiology, 1999, 59:4:355-396
  20. Expression of orphanin FQ and the opioid receptor-like (ORL1) receptor in the developing human and rat brain Charles R. Neal Jr., Huda Akil & Stanley J. Watson Jr. Journal of Chemical Neuroanatomy, 2002, 22:4:219 – 249
  21. Extracellular matrix molecules, long-term potentiation, memory consolidation and the brain angiotensin system John W. Wright, Enikö A. Kramár, Starla E. Meighan & Joseph W. Harding Peptides, 2002, 23:1:221-246
  22. Sequelae following traumatic brain injury: The cerebrovascular perspective Elke M. Golding Brain Research Reviews, 2002, 38:3:377-388
  23. Experimental strategies to promote axonal regeneration after traumatic central nervous system injury Christine C. Stichel & Hans Werner Müller Progress in Neurobiology, 1998, 56:2:119-148
  24. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Kent C. Berridge & Terry E. Robinson Brain Research Reviews, 1998, 28:3:309-369
  25. Transcranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanisms? [EP_effect_tig_render::dump] Unknown Tag A.AnkePostM.E.Martin E.Keck**Corresponding author. Tel.: +49-89-30622-314; fax: +49-89-30622-569keck@mpipsykl.mpg.deMax Planck Institute of Psychiatry, Kraepelinstrasse 2-10, D-80804 Munich, GermanyTranscranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanisms?Journal of Psychiatric Research354200107193-215> , please email this URL to the site administratorAnke Post & [EP_effect_tig_render::dump] Unknown Tag M.E.Martin E.Keck**Corresponding author. Tel.: +49-89-30622-314; fax: +49-89-30622-569keck@mpipsykl.mpg.deMax Planck Institute of Psychiatry, Kraepelinstrasse 2-10, D-80804 Munich, GermanyTranscranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanisms?Journal of Psychiatric Research354200107193-215> , please email this URL to the site administratorMartin E. Keck Journal of Psychiatric Research, 2001, 35:4:193-215
  26. Age and species-dependent differences in the neurokinin B system in rat and human brain D. Mileusnic, D.J. Magnuson, M.J. Hejna, J.B. Lorens, S.A. Lorens & J.M. Lee Neurobiology of Aging, 1999, 20:1:19-35
  27. The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling Steffen Roßner, Uwe Ueberham, Reinhard Schliebs, J. Regino Perez-Polo & Volker Bigl Progress in Neurobiology, 1998, 56:5:541-569
  28. Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization study D. Peckys & G. B. Landwehrmeyer Neuroscience, 1999, 88:4:1093-1135
  29. The cellular localization of the L-ornithine decarboxylase/polyamine system in normal and diseased central nervous systems Hans-Gert Bernstein & Michael Müller Progress in Neurobiology, 1999, 57:5:485-505
  30. Inflammation in the CNS: balance between immunological privilege and immune responses M. K. Matyszak Progress in Neurobiology, 1998, 56:1:19-35
  31. Compensatory mechanisms in experimental and human Parkinsonism: towards a dynamic approach Erwan Bezard & Christian E. Gross Progress in Neurobiology, 1998, 55:2:93-116
  32. Morphological and functional characterization of an in vitro blood–brain barrier model Kathe A. Stanness, Lesnick E. Westrum, Eleonora Fornaciari, Patrizia Mascagni, Jay A. Nelson, Stephan G. Stenglein, Tim Myers & Damir Janigro Brain Research, 1997, 771:2:329-342
  33. Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide Luisa Minghetti & Giulio Levi Progress in Neurobiology, 1998, 54:1:99-125
  34. The selective vulnerability of striatopallidal neurons I.J. Mitchell, A.J. Cooper & M.R. Griffiths Progress in Neurobiology, 1999, 59:6:691-719
  35. To be or not to be: adult neurogenesis and psychiatry Amelia J. Eisch & Eric J. Nestler Clinical Neuroscience Research, 2002, 2:1-2:93-108
  36. The origin and differentiation of microglial cells during development Miguel A. Cuadros & Julio Navascués Progress in Neurobiology, 1998, 56:2:173-189
  37. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain M. Glass, R. L. M. Faull & M. Dragunow Neuroscience, 1997, 77:2:299-318
  38. Expression of cholecystokinin, enkephalin, galanin and neuropeptide Y is markedly changed in the brain of the megencephaly mouse S. Petersson, C. Lavebratt, M. Schalling & T. Hökfelt Neuroscience, 2000, 100:2:297-317
  39. The role of cytokines and growth factors in seizures and their sequelae Joanna L. Jankowsky & Paul H. Patterson Progress in Neurobiology, 2001, 63:2:125-149
  40. Endogenous opiates: 1997 Gayle A. Olson, Richard D. Olson, Anthony L. Vaccarino & Abba J. Kastin Peptides, 1998, 19:10:1791-1843
  41. Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites Flavio Moroni European Journal of Pharmacology, 1999, 375:1-3:87-100
  42. Inflammation and glial responses in ischemic brain lesions Guido Stoll, Sebastian Jander & Michael Schroeter Progress in Neurobiology, 1998, 56:2:149-171
  43. Co-localization of GLUT1 and GLUT4 in the blood–brain barrier of the rat ventromedial hypothalamus Chardpraorn Ngarmukos, Elisabeth L. Baur & Arno K. Kumagai Brain Research, 2001, 900:1:1-8
  44. The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer’s disease Uwe Beffert, Marc Danik, Pascale Krzywkowski, Charles Ramassamy, Fouad Berrada & Judes Poirier Brain Research Reviews, 1998, 27:2:119-142
  45. Fetal tissue transplants in animal models of Huntington’s disease: the effects on damaged neuronal circuitry and behavioral deficits Naoyuki Nakao & Toru Itakura Progress in Neurobiology, 2000, 61:3:313-338
  46. Nervous system proteoglycans as modulators of neurite outgrowth Paola Bovolenta & Isabel Fernaud-Espinosa Progress in Neurobiology, 2000, 61:2:113-132
  47. Elements of cerebral microvascular ischaemia M.A. Petty & J.G. Wettstein Brain Research Reviews, 2001, 36:1:23-34
  48. Mitochondrial contributions to tissue damage in stroke Neil R. Sims & Michelle F. Anderson Neurochemistry International, 2002, 40:6:511-526
  49. Replicating Huntington’s disease phenotype in experimental animals Emmanuel Brouillet, Françoise Condé, M.F. Beal & Philippe Hantraye Progress in Neurobiology, 1999, 59:5:427-468
  50. Neurobehavioral effects of dietary soy phytoestrogens Edwin D. Lephart, Timothy W. West, K. Scott Weber, Reuben W. Rhees, Kenneth D.R. Setchell, Herman Adlercreutz & Trent D. Lund Neurotoxicology and Teratology, 2002, 24:1:5-16
  51. Immunohistochemical localization and quantification of glucose transporters in the mouse brain C. Choeiri, W. Staines & C. Messier Neuroscience, 2002, 111:1:19-34
  52. The subependymal layer in rodents: a site of structural plasticity and cell migration in the adult mammalian brain Paolo Peretto, Adalberto Merighi, Aldo Fasolo & Luca Bonfanti Brain Research Bulletin, 1999, 49:4:221-243
  53. The structural organization of connections between hypothalamus and cerebral cortex P.Y. Risold, R.H. Thompson & L.W. Swanson Brain Research Reviews, 1997, 24:2-3:197-254
  54. Neurotrophic factors in the primary olfactory pathway Alan Mackay-Sim & [EP_effect_tig_render::dump] Unknown Tag M.I.Meng InnChuahbaCentre for Molecular Neurobiology, School of Biomolecular and Biomedical Science, Griffith University, Brisbane, Qld 4111, AustraliabDivision of Anatomy and Physiology, University of Tasmania, GPO Box 252-24, Hobart, Tasmania 7001, AustraliaNeurotrophic factors in the primary olfactory pathwayProgress in Neurobiology62520001201527-559> , please email this URL to the site administratorMeng Inn Chuah Progress in Neurobiology, 2000, 62:5:527-559
  55. Cortical pathways to the mammalian amygdala Alexander J. McDonald Progress in Neurobiology, 1998, 55:3:257-332
  56. Fish neurotrophins and Trk receptors Gerhard Heinrich & Tom Lum International Journal of Developmental Neuroscience, 2000, 18:1:1-27
  57. Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes E.M. Muir, K.H. Adcock, D.A. Morgenstern, R. Clayton, N. von Stillfried, K. Rhodes, C. Ellis, J.W. Fawcett & J.H. Rogers Molecular Brain Research, 2002, 100:1-2:103-117
  58. Chemical anatomy of striatal interneurons in normal individuals and in patients with Huntington’s disease Francesca Cicchetti, Lucía Prensa, Ying Wu & André Parent Brain Research Reviews, 2000, 34:1-2:80-101
  59. Kainate-induced genes in the hippocampus: lessons from expression patterns Sylwia Zagulska-Szymczak, Robert K. Filipkowski & Leszek Kaczmarek Neurochemistry International, 2001, 38:6:485 – 501
  60. Glutamate receptors in the mammalian central nervous system Seiji Ozawa, Haruyuki Kamiya & Keisuke Tsuzuki Progress in Neurobiology, 1998, 54:5:581-618
  61. Dissecting glioma invasion: interrelation of adhesion, migration and intercellular contacts determine the invasive phenotype Elzbieta Kaczmarek, Svenja Zapf, Hakim Bouterfa, Jörg C. Tonn, Manfred Westphal & Alf Giese International Journal of Developmental Neuroscience, 1999, 17:5-6:625-641
  62. Neurotoxic consequences of central long-term administration of interleukin-2 in rats U.-K. Hanisch, J. Neuhaus, W. Rowe, D. van Rossum, T. Möller, H. Kettenmann & R. Quirion Neuroscience, 1997, 79:3:799-818
  63. The functions of the preplate in development and evolution of the neocortex and hippocampus H. Supèr, E. Soriano & H.B.M. Uylings Brain Research Reviews, 1998, 27:1:40-64
  64. Anti-oxidants prevent focal rat brain injury as assessed by induction of heat shock proteins (HSP70, HO-1/HSP32, HSP47) following subarachnoid injections of lysed blood Christopher P. Turner, S. Scott Panter & Frank R. Sharp Molecular Brain Research, 1999, 65:1:87-102
  65. The glial scar and central nervous system repair James W. Fawcett & Richard. A. Asher Brain Research Bulletin, 1999, 49:6:377-391
  66. Expression of brain-derived neurotrophic factor protein in the adult rat central nervous system Q. Yan, R. D. Rosenfeld, C. R. Matheson, N. Hawkins, O. T. Lopez, L. Bennett & A. A. Welcher Neuroscience, 1997, 78:2:431-448
  67. What role(s) for TGF in the central nervous system? [EP_effect_tig_render::dump] Unknown Tag M.-P.Marie-PierreJunierjunier@im3.inserm.frINSERM U421, Faculté de Médecine, 8, rue du Général Sarrail, 94010 Créteil, FranceWhat role(s) for TGF in the central nervous system?Progress in Neurobiology62520001201443-473> , please email this URL to the site administratorMarie-Pierre Junier Progress in Neurobiology, 2000, 62:5:443-473
  68. Brain macrophages: on the role of pericytes and perivascular cells W. Eric Thomas Brain Research Reviews, 1999, 31:1:42-57
  69. The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms Caleb E. Finch & Robert M. Sapolsky Neurobiology of Aging, 1999, 20:4:407-428
  70. New strategies for embedding, orientation and sectioning of small brain specimens enable direct correlation to MR-images, brain atlases, or use of unbiased stereology C.R. Bjarkam, M. Pedersen & J.C. Sørensen Journal of Neuroscience Methods, 2001, 108:2:153 – 159
  71. Neuroprotective effects of the N-terminal tripeptide of IGF-1, glycine-proline-glutamate, in the immature rat brain after hypoxic–ischemic injury Stéphane V. Sizonenko, Ernest S. Sirimanne, Chris E. Williams & Peter D. Gluckman Brain Research, 2001, 922:1:42-50
  72. Distinct roles for matrix metalloproteinase-2 and 4 integrin in autoimmune T cell extravasation and residency in brain parenchyma during experimental autoimmune encephalomyelitis Donnasue Graesser, Sepi Mahooti & Joseph A. Madri Journal of Neuroimmunology, 2000, 109:2:121-131
  73. Elevated glial brain-derived neurotrophic factor in Parkinson’s diseased nigra C. Knott, G. Stern, A. Kingsbury, A.A. Welcher & G.P. Wilkin Parkinsonism and Related Disorders, 2002, 8:5:329-341
  74. The yin and yang of tenascin-R in CNS development and pathology Penka Pesheva & Rainer Probstmeier Progress in Neurobiology, 2000, 61:5:465-493
  75. Intracarotid low dose bradykinin infusion selectively increases tumor permeability through activation of bradykinin B2 receptors in malignant gliomas Koichiro Matsukado, Masao Sugita & Keith L. Black Brain Research, 1998, 792:1:10-15
  76. Human prodynorphin gene generates several tissue-specific transcripts Miroslav Telkov, Thomas Geijer & Lars Terenius Brain Research, 1998, 804:2:284-295
  77. Infarct tolerance accompanied enhanced BDNF-like immunoreactivity in neuronal nuclei H. Yanamoto, I. Mizuta, I. Nagata, J.-H. Xue, Z. Zhang & H. Kikuchi Brain Research, 2000, 877:2:331-344
  78. Cellular distribution of the calcium-binding proteins parvalbumin, calbindin, and calretinin in the neocortex of mammals: phylogenetic and developmental patterns Patrick R. Hof, Ilya I. Glezer, Françoise Condé, Roxana A. Flagg, Marina B. Rubin, Esther A. Nimchinsky & Daniela M. Vogt Weisenhorn Journal of Chemical Neuroanatomy, 1999, 16:2:77 – 116
  79. Mu and kappa1 opioid-stimulated [35S]guanylyl-5′-o-(-thio)-triphosphate binding in cynomolgus monkey brain L.J. Sim-Selley, J.B. Daunais, L.J. Porrino & S.R. Childers Neuroscience, 1999, 94:2:651-662
  80. Reactive microgliosis Wolfgang J. Streit, Sharon A. Walter & Nathan A. Pennell Progress in Neurobiology, 1999, 57:6:563-581
  81. Characterization of mouse brain-specific angiogenesis inhibitor 1 (BAI1) and phytanoyl-CoA alpha-hydroxylase-associated protein 1, a novel BAI1-binding protein Jeong Tae Koh, Zang Hee Lee1, Kyu Youn Ahn, Jong Keun Kim, Choon Sang Bae, Hong-Hee Kim, Hae Jin Kee & Kyung Keun Kim Molecular Brain Research, 2001, 87:2:223-237
  82. The role of seizure-induced neurogenesis in epileptogenesis and brain repair Jack M. Parent Epilepsy Research, 2002, 50:1-2:179 – 189
  83. Benign focal ischemic preconditioning induces neuronal Hsp70 and prolonged astrogliosis with expression of Hsp27 R. William Currie, Julie A. Ellison, Ray F. White, Giora Z. Feuerstein, Xinkang Wang & Frank C. Barone Brain Research, 2000, 863:1-2:169-181
  84. Primary cortical glial reaction versus secondary thalamic glial response in the excitotoxically injured young brain: Astroglial response and metallothionein expression L. Acarin, B. González, J. Hidalgo, A.J. Castro & B. Castellano Neuroscience, 1999, 92:3:827-839
  85. Manipulation of gene expression in the mammalian nervous system: application in the study of neurite outgrowth and neuroregeneration-related proteins Anthony J.G.D. Holtmaat, A. Beate Oestreicher, Willem Hendrik Gispen & Joost Verhaagen Brain Research Reviews, 1998, 26:1:43-71
  86. The megencephaly mouse has disturbances in the insulin-like growth factor (IGF) system Susanna Petersson, Ann-Christin Sandberg Nordqvist, Martin Schalling & Catharina Lavebratt Molecular Brain Research, 1999, 72:1:80-88
  87. Ontogenic profile of the expression of the mu opioid receptor gene in the rat telencephalon and diencephalon: an in situ hybridization study Yiai Tong, Jean-Guy Chabot, Shi-Hsiang Shen, Brian F. O’Dowd, Susan R. George & Rémi Quirion Journal of Chemical Neuroanatomy, 2000, 18:4:209 – 222
  88. An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration David S. Cassarino & James P. Bennett Jr. Brain Research Reviews, 1999, 29:1:1-25
  89. Serine proteases and brain damage – is there a link? Melissa B. Gingrich & Stephen F. Traynelis Trends in Neurosciences, 2000, 23:9:399-407
  90. Animal models of cerebral -amyloid angiopathy Lary C. Walker Brain Research Reviews, 1997, 25:1:70-84
  91. Cellular signaling roles of TGF, TNF and APP in brain injury responses and Alzheimer’s disease Mark P. Mattson, Steven W. Barger, Katsutoshi Furukawa, Annadora J. Bruce, Tony Wyss-Coray, Robert J. Mark & Lennart Mucke Brain Research Reviews, 1997, 23:1-2:47-61
  92. The -ketoglutarate dehydrogenase complex in neurodegeneration Gary E. Gibson, Larry C.H. Park, [EP_effect_tig_render::dump] Unknown Tag K-F.R.Kwan-Fu RexSheuJohn P.BlassNoel Y.CalingasanDepartment of Neurology and Neuroscience, Weill Medical College of Cornell University, Burke Medical Research Institute, 785 Mamaroneck Avenue, White Plains, NY 10605, USAThe -ketoglutarate dehydrogenase complex in neurodegenerationNeurochemistry International36220000297-11219990909> , please email this URL to the site administratorKwan-Fu Rex Sheu, John P. Blass & Noel Y. Calingasan Neurochemistry International, 2000, 36:2:97-112
  93. Supraspinal metabolic activity changes in the rat during adjuvant monoarthritis F.L. Neto, J. Schadrack, A. Ableitner, J.M. Castro-Lopes, P. Bartenstein, W. Zieglgänsberger & T.R. Tölle Neuroscience, 1999, 94:2:607-621
  94. Subspecies of protein kinase C in the rat spinal cord Miki Akinori Progress in Neurobiology, 1998, 54:5:499-530
  95. Identification of a novel serine protease-like molecule in human brain Barbara Meckelein, Derek C.L. Marshall, Kelly-Jo Conn, Michael Pietropaolo, William Van Nostrand & Carmela R. Abraham Molecular Brain Research, 1998, 55:2:181-197
  96. Tumor necrosis factor- attenuates N-methyl-D-aspartate-mediated neurotoxicity in neonatal rat hippocampus Xiao-Hong Liu, Haiyan Xu & John D.E. Barks Brain Research, 1999, 851:1-2:94-104
  97. Measurement of human brain dexfenfluramine concentration by 19F magnetic resonance spectroscopy James D. Christensen, Deborah A. Yurgelun-Todd, Suzann M. Babb, Staci A. Gruber, Bruce M. Cohen & Perry F. Renshaw Brain Research, 1999, 834:1-2:1-5
  98. Functional magnetic resonance imaging of the human brain Seong-Gi Kim & Kamil Ugurbil Journal of Neuroscience Methods, 1997, 74:2:229-243
  99. Glutamate decarboxylase-67 messenger RNA expression in normal human basal ganglia and in Parkinson’s disease A. P. Nisbet, D. J. Eve, A. E. Kingsbury, S. E. Daniel, C. D. Marsden, A. J. Lees & O. J. F. Foster Neuroscience, 1996, 75:2:389-406
  100. Reelin immunoreactivity in the larval sea lamprey brain Emma Pérez-Costas, Miguel Meléndez-Ferro, Ysabel Santos, Ramón Anadón, M. Celina Rodicio & Héctor J. Caruncho Journal of Chemical Neuroanatomy, 2002, 23:3:211 – 221